Active, not recruiting
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
NCT02758717
- Conditions
- Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma, +8 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic Rochester, Minnesota, United States